Search research articles
Contact Us
Filters
Showing results (11-20 of 60) with videos related to
Page
of 6
Sort By:
ESMO Open
|
September 13, 2023
Artificial intelligence as an adjunct tool for breast oncologists - are we there yet?
I Schlam, M C Saad Menezes, C Corti, et al.
ESMO Open
|
April 13, 2024
Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer
G Curigliano, R Dent, H Earle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2022
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib
P Tarantino, Q Jin, E A Mittendorf, et al.
ESMO Open
|
September 17, 2024
Detection of antibody-drug conjugate-induced interstitial lung disease using circulating cell-free DNA
A Grinshpun, A Zick, T Perri, et al.
ESMO Open
|
October 8, 2025
Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study
S M Tolaney, L Spring, Y G Abdou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R Barroso-Sousa, E Jain, O Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
S M Tolaney, J Najita, J Sperinde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2025
Redefining clinical trial strategic design to support drug approval in medical oncology
G Antonarelli, J M Pérez-García, M Gion, et al.
ESMO Open
|
September 6, 2024
Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United States
S M Tolaney, K Punie, L A Carey, et al.
ESMO Open
|
March 20, 2026
Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia
H S Rugo, S M Tolaney, J Cortés, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 60) with videos related to
Sort By:
Page
of 6
ESMO Open
|
September 13, 2023
Artificial intelligence as an adjunct tool for breast oncologists - are we there yet?
I Schlam, M C Saad Menezes, C Corti, et al.
ESMO Open
|
April 13, 2024
Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer
G Curigliano, R Dent, H Earle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 7, 2022
Clinical and pathological features of breast cancer patients eligible for adjuvant abemaciclib
P Tarantino, Q Jin, E A Mittendorf, et al.
ESMO Open
|
September 17, 2024
Detection of antibody-drug conjugate-induced interstitial lung disease using circulating cell-free DNA
A Grinshpun, A Zick, T Perri, et al.
ESMO Open
|
October 8, 2025
Understanding first-line treatment patterns and survival outcomes across sociodemographic groups of women with metastatic triple-negative breast cancer in the United States: a real-world study
S M Tolaney, L Spring, Y G Abdou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 19, 2020
Prevalence and mutational determinants of high tumor mutation burden in breast cancer
R Barroso-Sousa, E Jain, O Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2013
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
S M Tolaney, J Najita, J Sperinde, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2025
Redefining clinical trial strategic design to support drug approval in medical oncology
G Antonarelli, J M Pérez-García, M Gion, et al.
ESMO Open
|
September 6, 2024
Real-world treatment patterns and outcomes in patients with HR+/HER2- metastatic breast cancer treated with chemotherapy in the United States
S M Tolaney, K Punie, L A Carey, et al.
ESMO Open
|
March 20, 2026
Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia
H S Rugo, S M Tolaney, J Cortés, et al.
Page
of 6